Search results for “Atypical hemolytic uremic syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 217 patents, we discovered top 24 key players by total patent application. Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Silence Therapeutics GmbH are dominant in this area. They take 71.89% of the total patent filing.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 109
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 28
Silence Therapeutics GmbH
Berlin, Germany
Patent: 19
Omeros Corp.
Washington, United States
Patent: 18
Eli Lilly & Co.
Indiana, United States
Patent: 7
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 4
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 2
Fuso Pharmaceutical Industries Ltd.
Osaka-fu, Japan
Patent: 2
Biotest Pharma GmbH
Hessen, Germany
Patent: 2
MicroCarb, Inc.
United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 117 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Alexion Pharmaceuticals, Inc., Silence Therapeutics GmbH, Omeros Corp. take 73.50% of patent filing during this period.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 53
Silence Therapeutics GmbH
Berlin, Germany
Patent: 19
Omeros Corp.
Washington, United States
Patent: 14
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
The National Centre For Cell Sciences
Maharashtra, India
Patent: 4
Shanghai Meiyue Biotechnology Dev Co Ltd
Shanghai Shi, China
Patent: 2
AbMax Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 2
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 1
University of Leicester
LEICESTER, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 117 patents in last 5 years, we discover 8 new entrants. Silence Therapeutics GmbH, The National Centre For Cell Sciences, Shanghai Meiyue Biotechnology Dev Co Ltd are the most active new entrants in this area.
Silence Therapeutics GmbH
Berlin, Germany
Patent: 19
The National Centre For Cell Sciences
Maharashtra, India
Patent: 4
Shanghai Meiyue Biotechnology Dev Co Ltd
Shanghai Shi, China
Patent: 2
AbMax Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 2
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 2
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Shanghai Puming Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 5 universities and scientific research institutions by total patent application. The Johns Hopkins University, University of Leicester, Consejo Superior de Investigaciones Científicas are dominant in this area. They take 93.75% of the total patent filing.
The Johns Hopkins University
United States
Patent: 5
University of Leicester
LEICESTER, United Kingdom
Patent: 5
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 2
Jilin University
Jilin Sheng, China
Patent: 1
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: